EARLY CHILDHOOD INFECTION WITH HUMAN HERPES VIRUS TYPE 6 (HHV-6) AS A PROTECTION AGAINST THE DEVELOPMENT OF IGE SENSITIZATION, ATOPIC DISEASE AND ALLERGY IN YOUNG CHILDREN.

摘要

The present invention discloses a use of human herpes virus 6 (HHV-6) orderivatives thereof, for the manufacture of a pharmaceutical compositionintended to be administered during early childhood, for the prevention of IgEsensitization and allergy development in young children. Examples of viralcompositions include, but are not limited to live human herpes virus 6 (HHV-6).